This is not a first-line option for pharmacological treatment of gout

The correct option is Aspirin.

Gout is a painful form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints and tissues. The primary goal of pharmacological treatment during an acute gout flare is to reduce inflammation and pain quickly and effectively. First-line therapies for managing acute gout flares include:
1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Fast-acting agents that reduce pain and inflammation.
2. Corticosteroids: Highly effective anti-inflammatory agents, especially useful for patients who cannot tolerate NSAIDs or colchicine.
3. Oral Colchicine: An anti-inflammatory medication that prevents the polymerization of tubulin, thereby inhibiting leukocyte migration and activation in response to urate crystals.

Why Aspirin is not a first-line option:
Aspirin (acetylsalicylic acid), although an NSAID, is specifically avoided or not used as a first-line agent during an acute gout flare because of its complex, dose-dependent effects on uric acid excretion in the kidneys. At low doses, aspirin inhibits the renal active secretion of uric acid, which can lead to elevated levels of uric acid in the blood (hyperuricemia) and potentially prolong or worsen the acute gout attack. Consequently, aspirin is contraindicated or avoided in the acute management of gout.